China Resources Pharma hits more than 4-month peak on higher FY profit, dividend

China Resources Pharmaceutical

25/03/2026 03:08

** China Resources Pharmaceutical Group 3320.HK jumps 10.6% to HK$4.92, highest since November 19

** Stock on course for biggest one-day pct rise since January 2022; top pct gainer on Hang Seng Biotech Index .HSBIO, which is up 0.4%

** Chinese pharmaceuticals and health products maker's 2025 net profit jumps 20.7% y/y

** Co declares final dividend of 0.122 yuan/share vs year-ago 0.052 yuan

** YTD, stock up 10.1%

($1 = 6.8905 Chinese yuan renminbi)

 (Reporting by Donny Kwok)

 ((donny.kwok@thomsonreuters.com))